Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan
about
The clinical significance of PR, ER, NF- κ B, and TNF- α in breast cancerDatamining approach for automation of diagnosis of breast cancer in immunohistochemically stained tissue microarray images.Efficacy of TCH/TEC neoadjuvant chemotherapy for the treatment of HER-2-overexpressing breast cancer.First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases.Pathobiological features of breast tumours in the State of Kuwait: a comprehensive analysis.Estrogen receptor, progesterone receptor, and Her 2 Neu positivity and its association with tumour characteristics and menopausal status in a breast cancer cohort from northern Pakistan.Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma.Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in invasive breast cancer in women.Postmenopausal Breast Cancer Risk in Relation to Antibodies Specific to Benzo[a]Pyrene, Estradiol and Progesterone.Systematic review of breast cancer biology in developing countries (part 1): Africa, the middle East, eastern europe, Mexico, the Caribbean and South americaDetection of HER-2/neu, c-myc amplification and p53 inactivation by FISH in Egyptian patients with breast cancer.Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast.Jordanian and Palestinian immigrant women's knowledge, affect, cultural attitudes, health habits, and participation in breast cancer screening.Automation of immunohistochemical evaluation in breast cancer using image analysis.Changing frequency of equivocal HER-2/neu scores and factors predictive of negative HER 2/neu fluorescent in situ hybridisation in invasive carcinomas of the breast.A nomogram to predict HER2 status in breast cancer patients with HER2-borderline disease as determined via immunohistochemistry.Correlation of Hormone Receptor and Human Epidermal Growth Factor Receptor-2/neu Expression in Breast Cancer with Various Clinicopathologic Factors.Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma.Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancerEvaluation of Immunohistochemical Profile of Breast Cancer for Prognostics and Therapeutic Use
P2860
Q33597991-93F8E9B1-B6DE-48D4-B378-D5D0B25F7306Q34982979-B6639646-32D5-4870-A454-38757E13E4DBQ35167644-E7E28170-E4BB-4095-AAD2-5A2722B22AB5Q36244761-29F809D9-0DBC-4A8D-96F5-CD398D451C69Q36316069-5215EA50-E6D2-4290-973F-29A426271128Q36489321-42D6A988-FCA4-4E6C-84C3-E74BD488906BQ36960615-5358FDAF-B318-4A71-A7DF-75FAAC43A909Q36983960-DF822D55-DE0E-445D-B985-1295FA978AFBQ37111064-042E70AC-2B07-4466-BAF8-46270ED0F43FQ37132777-8E1B5807-C1AF-46C5-963F-F87C27436E08Q37277274-84AE3462-7C13-4A04-BD8E-973ECF442701Q39929779-2AA97197-140E-4B4D-922C-362307B331A6Q39957637-5BC5D7E6-C7AE-4793-B4F9-CBAD63AA37B8Q42738160-5849A461-38AE-4EE5-892F-875C3AB8C0EFQ44619359-49BDD0A0-9C5F-46B7-9775-A592BDF361B3Q47127531-BD1CED73-9598-4F5A-B831-9837DA8BC167Q49879088-2BFEE4FB-9CAA-4EEC-B65C-7CEE9A631A91Q54607534-E28A434F-5A0E-43A3-8E98-0DA97D3FF1FAQ57071121-16CD5410-A29D-403D-A041-4C6A8164DCAAQ57142597-85A2AF74-52B9-45CC-A211-2C41DBDEC205
P2860
Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Immunohistochemical evaluation ...... in breast carcinoma in Jordan
@ast
Immunohistochemical evaluation ...... in breast carcinoma in Jordan
@en
Immunohistochemical evaluation ...... in breast carcinoma in Jordan
@nl
type
label
Immunohistochemical evaluation ...... in breast carcinoma in Jordan
@ast
Immunohistochemical evaluation ...... in breast carcinoma in Jordan
@en
Immunohistochemical evaluation ...... in breast carcinoma in Jordan
@nl
prefLabel
Immunohistochemical evaluation ...... in breast carcinoma in Jordan
@ast
Immunohistochemical evaluation ...... in breast carcinoma in Jordan
@en
Immunohistochemical evaluation ...... in breast carcinoma in Jordan
@nl
P2860
P3181
P356
P1476
Immunohistochemical evaluation ...... in breast carcinoma in Jordan
@en
P2093
Mohammad Al Hamad
Nidal M Almasri
P2860
P2888
P304
P3181
P356
10.1186/BCR1200
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1039259103